Literature DB >> 19216030

Chronic estradiol replacement to aged female rats reduces anxiety-like and depression-like behavior and enhances cognitive performance.

Alicia A Walf1, Jason J Paris, Cheryl A Frye.   

Abstract

Decline in the ovarian steroid, estradiol (E(2)), with the menopause transition may influence cognitive and affective processing of older women and there is evidence that hormone replacement therapies (HRTs) with E(2)-mimetics may provide benefit in some, but not all, women. The parameters that play a role in determining whether the response to HRTs is positive are of interest. It may be that the likelihood for positive responses is related to the timing of E(2)-replacement following E(2) decline. As such, in the present study an animal model was utilized to investigate this. We investigated the effects of long- versus short-term E(2)-replacement by examining cognitive (object placement task), anxiety (open field, mirror maze, light-dark transition task), and depression (forced swim task) behavior of female rats that were ovariectomized (OVX) at middle-age (14 months) or older (19 months) and implanted with E(2)-filled implants at the time of surgery or after a delay of 5 months, or OVX at 14 months of age and never replaced with E(2). Rats were tested at 20 months of age. The hypothesis that was tested was that rats would have reduced anxiety and depression behavior and improved cognitive performance with E(2)-replacement at ovarian cessation, compared to a delay in E(2)-replacement. Performance in the object placement task was improved in rats that were OVX and then received continuous E(2)-replacement, compared to those that were OVX and continuously administered placebo vehicle. In the open field and forced swim task, there was an increase in anti-anxiety and anti-depression behavior, respectively, among rats that were OVX and then received continuous E(2)-replacement, compared to OVX rats administered vehicle or those that experienced a delay in E(2)-replacement. In the mirror maze and light-dark transition task, E(2)-replacement at OVX, or after a delay, reduced anxiety-like behavior. Thus, E(2)-replacement reduced anxiety and depression behavior and improved cognitive performance of aged female rats; however, delay in E(2) treatment influenced whether there were favorable effects of E(2) in some tasks.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19216030      PMCID: PMC2696690          DOI: 10.1016/j.psyneuen.2009.01.004

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  52 in total

1.  Progesterone in conjunction with estradiol has neuroprotective effects in an animal model of neurodegeneration.

Authors:  J M Vongher; C A Frye
Journal:  Pharmacol Biochem Behav       Date:  1999-12       Impact factor: 3.533

2.  Long-term ovarian hormone deprivation alters the ability of subsequent oestradiol replacement to regulate choline acetyltransferase protein levels in the hippocampus and prefrontal cortex of middle-aged rats.

Authors:  J Bohacek; A M Bearl; J M Daniel
Journal:  J Neuroendocrinol       Date:  2008-05-06       Impact factor: 3.627

3.  Effects of estrogen on activity and fear-related behaviors in mice.

Authors:  M A Morgan; D W Pfaff
Journal:  Horm Behav       Date:  2001-12       Impact factor: 3.587

4.  Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients.

Authors:  L Linzmayer; H V Semlitsch; B Saletu; G Böck; G Saletu-Zyhlarz; A Zoghlami; D Gruber; M Metka; J Huber; M Oettel; T Gräser; J Grünberger
Journal:  Arzneimittelforschung       Date:  2001

5.  Estradiol tends to improve inhibitory avoidance performance in adrenalectomized male rats and reduces pyknotic cells in the dentate gyrus of adrenalectomized male and female rats.

Authors:  C A Frye
Journal:  Brain Res       Date:  2001-01-19       Impact factor: 3.252

6.  Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats.

Authors:  R B Gibbs
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

7.  High-dose estradiol improves cognition for women with AD: results of a randomized study.

Authors:  S Asthana; L D Baker; S Craft; F Z Stanczyk; R C Veith; M A Raskind; S R Plymate
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

8.  Acetylcholine mediates the estrogen-induced increase in NMDA receptor binding in CA1 of the hippocampus and the associated improvement in working memory.

Authors:  J M Daniel; G P Dohanich
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

9.  Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression.

Authors:  L A Galea; J K Wide; A M Barr
Journal:  Behav Brain Res       Date:  2001-07       Impact factor: 3.332

10.  Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3alpha,5alpha-THP.

Authors:  C A Frye; S M Petralia; M E Rhodes
Journal:  Pharmacol Biochem Behav       Date:  2000-11       Impact factor: 3.533

View more
  42 in total

1.  Neurobiological Underpinnings of the Estrogen - Mood Relationship.

Authors:  Whitney Wharton; Carey E Gleason; Sandra R M S Olson; Cynthia M Carlsson; Sanjay Asthana
Journal:  Curr Psychiatry Rev       Date:  2012-08-01

2.  Impact of physiologic estrogen replacement on anxiety symptoms, body shape perception, and eating attitudes in adolescent girls with anorexia nervosa: data from a randomized controlled trial.

Authors:  Madhusmita Misra; Debra K Katzman; Nara Mendes Estella; Kamryn T Eddy; Thomas Weigel; Mark A Goldstein; Karen K Miller; Anne Klibanski
Journal:  J Clin Psychiatry       Date:  2013-08       Impact factor: 4.384

Review 3.  Pituitary adenylate cyclase activating polypeptide (PACAP), stress, and sex hormones.

Authors:  S Bradley King; Donna J Toufexis; Sayamwong E Hammack
Journal:  Stress       Date:  2017-06-14       Impact factor: 3.493

4.  II. Cognitive performance of middle-aged female rats is influenced by capacity to metabolize progesterone in the prefrontal cortex and hippocampus.

Authors:  Jason J Paris; Alicia A Walf; Cheryl A Frye
Journal:  Brain Res       Date:  2010-10-31       Impact factor: 3.252

5.  Conjugated equine estrogen, with medroxyprogesterone acetate, enhances formation of 5alpha-reduced progestogens and reduces anxiety-like behavior of middle-aged rats.

Authors:  Cheryl A Frye; Alicia A Walf; Jason J Paris
Journal:  Behav Pharmacol       Date:  2010-09       Impact factor: 2.293

Review 6.  Sex-dependent mental illnesses and mitochondria.

Authors:  Akiko Shimamoto; Virginie Rappeneau
Journal:  Schizophr Res       Date:  2017-03-06       Impact factor: 4.939

7.  Effect of different doses of estrogen on the nigrostriatal dopaminergic system in two 6-hydroxydopamine-induced lesion models of Parkinson's disease.

Authors:  Marcela Ferreira Cordellini; Giovana Piazzetta; Karin Cristine Pinto; Ana Márcia Delattre; Francesca Matheussi; Ruither O G Carolino; Raphael Escorsim Szawka; Janete A Anselmo-Franci; Anete Curte Ferraz
Journal:  Neurochem Res       Date:  2011-02-24       Impact factor: 3.996

8.  Estrogen levels are associated with extinction deficits in women with posttraumatic stress disorder.

Authors:  Ebony M Glover; Tanja Jovanovic; Kristina B Mercer; Kimberly Kerley; Bekh Bradley; Kerry J Ressler; Seth D Norrholm
Journal:  Biol Psychiatry       Date:  2012-04-12       Impact factor: 13.382

9.  Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis?

Authors:  Michal Arad; Ina Weiner
Journal:  Neuropsychopharmacology       Date:  2010-03-17       Impact factor: 7.853

10.  Inhibition of fear is differentially associated with cycling estrogen levels in women.

Authors:  Ebony M Glover; Kristina B Mercer; Seth D Norrholm; Michael Davis; Erica Duncan; Bekh Bradley; Kerry J Ressler; Tanja Jovanovic
Journal:  J Psychiatry Neurosci       Date:  2013-09       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.